# References

SM Vindigni, TL Zisman et al.

Turnbaugh, P., Hamady, M., Yatsunenko, T., Cantarel, B., Duncan, A., Ley, R. et al. (2009) A core gut microbiome in obese and lean twins. Nature 457: 480–484.

Turner, D., Levine, A., Kolho, K., Shaoul, R. and Ledder, O. (2014) Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report. J Crohns Colitis 8: 1464–1470.

Turner, J. (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799–809.

Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. et al. (2010) Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 105: 2218–2227.

Ulluwishewa, D., Anderson, R., McNabb, W., Moughan, P., Wells, J. and Roy, N. (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141: 769–776.

Ursell, L., Metcalf, J., Parfrey, L. and Knight, R. (2012) Defining the human microbiome. Nutr Rev 70(Suppl. 1): S38–S44.

Van Immerseel, F., Ducatelle, R., De Vos, M., Boon, N., Van De Wiele, T., Verbeke, K. et al. (2010) Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol 59: 141–143.

Van Limbergen, J., Radford-Smith, G. and Satsangi, J. (2014) Advances in IBD genetics. Nat Rev Gastroenterol Hepatol 11: 372–385.

Van Nimwegen, F., Penders, J., Stobberingh, E., Postma, D., Koppelman, G., Kerkhof, M. et al. (2011) Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol 128: 948–955 e941–943.

Voitk, A., Echave, V., Feller, J., Brown, R. and Gurd, F. (1973) Experience with elemental diet in the treatment of inflammatory bowel disease. is this primary therapy? Arch Surg 107: 329–333.

Wang, M., Ahrne, S., Jeppsson, B. and Molin, G. (2005) Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 54: 219–231.

Wang, N., Wang, G., Hao, J., Ma, J., Wang, Y., Jiang, X. et al. (2012) Curcumin ameliorates hydrogen peroxide-induced epithelial barrier disruption by upregulating heme oxygenase-1 expression in human intestinal epithelial cells. Dig Dis Sci 57: 1792–1801.

Willing, B., Dicksved, J., Halfvarson, J., Andersson, A., Lucio, M., Zheng, Z. et al. (2010) A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139: 1844–1854.e1841.

Wischmeyer, P. (2007) Glutamine: mode of action in critical illness. Crit Care Med 35: S541–544.

Wolff, M., Broadhurst, M. and Loke, P. (2012) Helminthic therapy: improving mucosal barrier function. Trends Parasitol 28: 187–194.

Wu, G., Bushmanc, F. and Lewis, J. (2013) Diet, the human gut microbiota, and IBD. Anaerobe 24: 117–120.

Wu, G., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y., Keilbaugh, S. et al. (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105–108.

Zhang, F., Wang, H., Wang, M., Cui, B., Fan, Z. and Ji, G. (2013) Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn’s disease. World J Gastroenterol 19: 7213–7216.

Zhang, Y. and Li, Y. (2014) Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20: 91–99.

Zoetendal, E., Rajilic-Stojanovic, M. and De Vos, W. (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57: 1605–1615.

Visit SAGE journals online http://tag.sagepub.com